Clinical trials
Muscular Diseases trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Terminated | 3 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 2 |
| Centre d'Investigation Clinique et Technologique 805 | 2 |
| Institut National de la Santé Et de la Recherche Médicale, France | 2 |
| Institut de Myologie, France | 2 |
| PTC Therapeutics | 2 |
| Abcuro, Inc. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| AstraZeneca | 1 |
| Avidity Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Diseases | 29 |
| Musculoskeletal Diseases | 10 |
| Neuromuscular Diseases | 10 |
| Muscular Dystrophies | 9 |
| Nervous System Diseases | 8 |
| Genetic Diseases, Inborn | 6 |
| Muscular Dystrophy, Duchenne | 6 |
| Muscular Disorders, Atrophic | 5 |
| Myositis | 5 |
| Myotonic Dystrophy | 5 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.